Establishment Labs Holdings reported Q3 2026 sales of US$71.99 million and a net loss of US$10.71 million, with nine month sales at US$199.41 million and a loss of US$35.84 million, while also narrowing basic loss per share versus the prior year periods. The business coupled higher sales with a reduced loss profile and increased its 2026 revenue outlook to more than US$274 million. This signals management’s confidence in demand and operating execution. We will now look at how Establishment...
Motley Fool Press Release.
Detailed price information for GE Healthcare Technologies (GEHC-Q) from The Globe and Mail including charting and trades.
Establishment Labs Hldgs (NASDAQ:ESTA) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. Benzinga APIs provide real-time
For growth investors, Establishment Labs Holdings (NASDAQ:ESTA) presents a compelling equity thesis: a medical aesthetics disruptor transitioning from cash-burning expansion to sustainable, profitable scale. Evaluating the company’s long-term fundamentals, such as its trajectory of multi-year revenue growth, operating cash flow generation, return on invested capital/ROIC, and ultimate free cash flow conversion, reveals a business at […]
NEW YORK, September 21, 2026--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced the presentation of new clinical and scientific data supporting Breast Tissue Preservation and its Minimally Invasive Platform. Establishment Labs also announced the product line extensions of both Mia® and Preservé™ with new sizes and supporting tools. The announcement
Detailed price information for Mckesson Corp (MCK-N) from The Globe and Mail including charting and trades.
This is the newest page. Registered accounts read further back.